Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-059984

COO & Chief Financial Officer sold 4,963 shares at $98.50 ($488,856)

  • COO & Chief Financial Officer acquired 4,963 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LOWE CHRISTOPHER P. COO & Chief Financial Officer 2021-10-05 Option exercise +4,963 $54.85 $272,221 64,963 D: show line 1 in the form
LOWE CHRISTOPHER P. COO & Chief Financial Officer 2021-10-05 Sale −4,963 $98.50 $488,856 60,000 D: show line 2 in the form
Open-market sales · 4,963 sh · avg $98.50 · $488,856

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
LOWE CHRISTOPHER P. COO & Chief Financial Officer 2021-10-05 Option exercise · Stock Option (Right to Buy) −4,963 95,037 D: show line 3 in the form
Loading xslF345X03/doc4.xml…